Canada markets closed

ImmunoPrecise Antibodies Ltd. (IPA)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.2800+0.0200 (+1.59%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 33.68M
Enterprise Value 39.67M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.87
Price/Book (mrq)0.93
Enterprise Value/Revenue 1.68
Enterprise Value/EBITDA -4.13

Trading Information

Stock Price History

Beta (5Y Monthly) 0.33
52-Week Change 3-54.01%
S&P500 52-Week Change 322.38%
52 Week High 34.2200
52 Week Low 30.9400
50-Day Moving Average 31.4974
200-Day Moving Average 31.7115

Share Statistics

Avg Vol (3 month) 3605.62k
Avg Vol (10 day) 382.77k
Shares Outstanding 526.32M
Implied Shares Outstanding 626.32M
Float 822.79M
% Held by Insiders 113.59%
% Held by Institutions 16.73%
Shares Short (Apr 15, 2024) 4339.99k
Short Ratio (Apr 15, 2024) 40.21
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 41.29%
Shares Short (prior month Mar 15, 2024) 4440.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 23, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Nov 23, 2020

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Apr 30, 2023
Most Recent Quarter (mrq)Jan 31, 2024

Profitability

Profit Margin -60.22%
Operating Margin (ttm)-53.69%

Management Effectiveness

Return on Assets (ttm)-10.98%
Return on Equity (ttm)-25.72%

Income Statement

Revenue (ttm)23.68M
Revenue Per Share (ttm)0.94
Quarterly Revenue Growth (yoy)20.30%
Gross Profit (ttm)N/A
EBITDA -12.21M
Net Income Avi to Common (ttm)-14.26M
Diluted EPS (ttm)-0.4200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.2M
Total Cash Per Share (mrq)0.24
Total Debt (mrq)14.39M
Total Debt/Equity (mrq)28.89%
Current Ratio (mrq)1.66
Book Value Per Share (mrq)1.89

Cash Flow Statement

Operating Cash Flow (ttm)-3.84M
Levered Free Cash Flow (ttm)-858k